Neil Rown
Bioprocessing, the application of biological processes in the manufacturing of products, has emerged as a key technology in the production of antiviral biologics. These biologics, which include vaccines, antibodies, and other therapeutic proteins, have revolutionized the prevention and treatment of diseases caused by viral pathogens. With their ability to target specific viral components or modulate the immune response, antiviral biologics offer significant advantages over traditional small-molecule drugs. This article explores how bioprocessing techniques contribute to the efficient production of antiviral biologics, thus enabling their widespread availability and improved clinical outcomes.
इस लेख का हिस्सा
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Telugu 